OTC · HNGZY
Healthcare · Medical - Diagnostics & Research
$4.45
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 5:37 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
HNGZY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning HNGZY.
HNGZY research
Company profile and research snapshot.
HANGZHOU TIGRMD UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 28, 2026
Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its 2026 interim results (the "Reporting Period").
SeekingAlpha · Jan 16, 2026
2026-01-16. The following slide deck was published by Hangzhou Tigermed Consulting Co., Ltd in conjunction with this event.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HNGZY.
No results
No recent SID articles mention HNGZY.
